Rolling back malaria in Africa - challenges and opportunities to winning the elimination battle.

A high-level review was conducted of the literature pertaining to the challenges and opportunities for eliminating malaria on the African continent. Although malaria mortality and morbidity are on the decline, the disease remains one of public health importance. Africa has invariably borne the brunt of the disease, recording the highest number of cases and deaths. However, with greater emphasis being placed on the disease by the international community, partnerships have developed to boost malaria elimination efforts on the continent. One such initiative is the Roll Back Malaria (RBM) partnership which aims to facilitate malaria elimination through increasing resources and awareness. Many cross-border initiatives have been established which treat malaria as a regional problem rather than a country-specific one. Accelerated malaria control efforts have led to a 37% decrease in cases and 60% reduction in deaths. Multi-country efforts have resulted in marked reductions of transmission in the region. Although there have been noteworthy gains in curtailing the disease, new challenges have arisen. The main among these are residual malaria and outdoor biting. One of the main drivers of residual malaria is insecticide resistance. Adding to the burden of residual transmission is the discovery of new vectors that may exist at low densities. To exacerbate these issues is the challenge of malaria imported from high- to low-transmission areas. Nevertheless, compared with the historical picture, we are winning the battle against malaria. Countries in Africa are being certified malaria-free. Partnerships have been developed to take forward the RBM Global Malaria Action Plan. Elimination agendas can only be successful if funding remains sustainable, with greater reliance on domestic funding.

Evaluation of methods and costs for detecting methicillin-resistant Staphylococcus aureus isolates from clinical specimens at regional hospitals in Trinidad and Tobago / Evaluación de métodos y costos para la detección de aislados de Staphylococcus aureus resistentes a la meticilina a partir de especímenes clínicos en los hospitales regionales de Trinidad y Tobago

OBJECTIVES: To evaluate and determine the most cost effective, rapid and specific method for detection of methicillin resistance in clinical isolates of S aureus in a setting with limited personnel and resources. METHODS: Standard laboratory methods were used to identify S aureus isolates. The conventional Methicillin Resistance Staphylococcus aureus (MRSA) detection methods used included, 1 µg oxacillin disk diffusion, oxacillin salt agar screen (CLSI), penicillin binding protein (PBP 2') latex agglutination test and E-tests oxacillin. Results of conventional tests were compared with a polymerase chain reaction (PCR) method for detecting MRSA isolates. Polymerase chain reaction detection of the mecA gene in S aureus was used as the " gold standard" for MRSA identification. RESULTS: All methods had 100% sensitivity except for oxacillin disk diffusion and oxacillin-salt agar screening with 98% and 99%, respectively. Specificity was also 100% for all methods except for oxacillin-disk diffusion (99%). Turn around time (TAT) for detection of MRSA was calculated to be within six hours for PCR. The fastest TAT of 1.25 hours was obtained for PBP 2' latex agglutination. Total cost for labour and materials to perform each method was highest for E-test, US$13.76/isolate. The cost for PCR when compared to that of latex agglutination was not statistically significant (US$3.74 vs US5.91, p = 0.4). CONCLUSIONS: All methods presented high sensitivity and specificity, but the latex agglutination test had the advantage of giving a reliable, rapid and most cost effective result that compares well to PCR in this environment.

OBJETIVOS: Evaluar y determinar el método más específico, rápido y costo-efectivo para la detección de la resistencia a la meticilina en aislados clínicos de S aureus en un lugar con personal y recursos limitados. MÉTODOS: A fin de identificar los aislados de S aureus, se utilizaron métodos estándar de laboratorio. Los métodos convencionales de detección de SARM usados incluyeron difusión por disco de oxacilina de 1 µg, prueba de tamizaje (" screening" ) de oxacilina en agar-sal (CLSI), test de aglutinación en látex para la detección de la proteína 2 fijadora de la penicilina (PBP 2'), y la prueba E-Test de oxacilina. Los resultados de las pruebas convencionales fueron comparados con un método de PCR para la detección de aislados SARM. La detección por PCR del gene mecA en S aureus fue usada como " estándar de oro" para la identificación de SARM. RESULTADOS: Todos los métodos tuvieron 100% de sensibilidad excepto la difusión por disco de oxacilina y el tamizaje de oxacilina en agar-sal, con 98% y 99% respectivamente. La especificad también fue de 100% para todos los métodos, con excepción de la difusión por disco de oxacilina (99%). El tiempo de respuesta (TAT, del inglés turn around time) para la detección de SARM se halla, según los cálculos, dentro de las seis horas para PCR. El TAT más rápido, 1.25 hrs, se obtuvo en la aglutinación en látex de PBP 2'. El costo total del trabajo y los materiales en la ejecución de cada método fue más alto en la prueba de E-Test, aislado/$13.76 USD. El costo de PCR en comparación con el de la aglutinación látex no fue estadísticamente significativo ($3.74 USD vs $5.91USD, p = 0.4). CONCLUSIONES: Todos los métodos presentaron alta sensibilidad y especificidad, pero el test de aglutinación en látex tuvo como ventaja el ofrecer un resultado confiable, rápido y altamente costo-efectivo, no muy diferente del PCR en este ambiente.

Evaluation of methods and costs for detecting methicillin-resistant Staphylococcus aureus isolates from clinical specimens at regional hospitals in Trinidad and Tobago.

OBJECTIVES: To evaluate and determine the most cost effective, rapid and specific method for detection of methicillin resistance in clinical isolates of S. aureus in a setting with limited personnel and resources. METHODS: Standard laboratory methods were used to identify S. aureus isolates. The conventional Methicillin Resistance Staphylococcus aureus (MRSA) detection methods used included, 1 microg oxacillin disk diffusion, oxacillin salt agar screen (CLSI), penicillin binding protein (PBP 2') latex agglutination test and E-tests oxacillin. Results of conventional tests were compared with a polymerase chain reaction (PCR) method for detecting MRSA isolates. Polymerase chain reaction detection of the mecA gene in S. aureus was used as the "gold standard" for MRSA identification. RESULTS: All methods had 100% sensitivity except for oxacillin disk diffusion and oxacillin-salt agar screening with 98% and 99%, respectively. Specificity was also 100% for all methods except for oxacillin-disk diffusion (99%). Turn around time (TAT) for detection of MRSA was calculated to be within six hours for PCR. The fastest TAT of 1.25 hours was obtained for PBP 2' latex agglutination. Total cost for labour and materials to perform each method was highest for E-test, US$13.76/isolate. The cost for PCR when compared to that of latex agglutination was not statistically significant (US$3.74 vs US5.91, p = 0.4). CONCLUSIONS: All methods presented high sensitivity and specificity, but the latex agglutination test had the advantage of giving a reliable, rapid and most cost effective result that compares well to PCR in this environment.